当前位置:首页 - 行情中心 - 冠昊生物(300238) - 财务分析

冠昊生物

(300238)

  

流通市值:41.63亿  总市值:41.63亿
流通股本:2.65亿   总股本:2.65亿

冠昊生物(300238)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润0.20亿元,每股收益0.10元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益49349.29万元,未分配利润-29164.03万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产77450.69万元,负债28101.40万元。

利润表
报告期2025-09-302025-06-302025-03-312024-12-31
营业总收入293,480,433.06200,869,647.9894,797,135.39377,483,103.8
营业总成本261,309,394.44176,257,580.5576,040,276.86334,942,285.38
其他经营收益
营业利润31,441,561.0223,980,044.8417,848,423.4228,243,591.47
利润总额32,119,529.5224,785,692.0419,106,612.7328,019,278.3
净利润20,429,167.5316,512,890.1714,727,786.5516,607,493.45
每股收益
其他综合收益-69,791.15-75,889.46-16,948.9174,362.59
综合收益总额20,359,376.3816,437,000.7114,710,837.6416,681,856.04
资产负债表
报告期2025-09-302025-06-302025-03-312024-12-31
流动资产:
流动资产合计300,732,354.2304,563,094.8282,432,258.91265,789,737.12
非流动资产:
非流动资产合计473,774,578.98478,205,473.28481,810,551.95488,610,094.29
资产总计774,506,933.18782,768,568.08764,242,810.86754,399,831.41
流动负债:
流动负债合计152,297,698.75164,814,764.13145,955,381.56177,990,961.77
非流动负债:
非流动负债合计128,716,346.25128,034,531.24129,973,588.16108,816,966.42
负债合计281,014,045292,849,295.37275,928,969.72286,807,928.19
所有者权益(或股东权益):
归属于母公司股东权益合计572,121,327.51565,800,826.75557,207,253542,358,105.24
股东权益合计493,492,888.18489,919,272.71488,313,841.14467,591,903.22
负债和股东权益合计774,506,933.18782,768,568.08764,242,810.86754,399,831.41
现金流量表
报告期2025-09-302025-06-302025-03-312024-12-31
经营活动产生的现金流量:
经营活动现金流入小计337,580,752.35220,818,693.53107,890,735.24430,623,758.38
经营活动现金流出小计284,944,912.18181,539,565.2892,819,977.44381,068,961.39
经营活动产生的现金流量净额52,635,840.1739,279,128.2515,070,757.849,554,796.99
投资活动产生的现金流量:
投资活动现金流入小计27,914.3527,914.3524,119.3598,550
投资活动现金流出小计30,788,916.9325,434,157.2624,933,790.4385,047,603.96
投资活动产生的现金流量净额-30,761,002.58-25,406,242.91-24,909,671.08-84,949,053.96
筹资活动产生的现金流量:
筹资活动现金流入小计42,051,30030,101,30030,101,30085,000,000
筹资活动现金流出小计26,871,520.767,393,425.022,865,911.6941,405,469.43
筹资活动产生的现金流量净额15,179,779.2422,707,874.9827,235,388.3143,594,530.57
汇率变动对现金及现金等价物的影响-103,782.15-113,482.72-25,515.77175,121.04
现金及现金等价物净增加额36,950,834.6836,467,277.617,370,959.268,375,394.64
期末现金及现金等价物余额141,434,634.79140,951,077.71121,854,759.37104,483,800.11
补充资料:
现金及现金等价物的净增加额-36,467,277.6-8,375,394.64
TOP↑